Insider Actions for Gilead Sciences Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 05/05/2022 |
Kevin E. Lofton Director |
2,444 | Award at $0 per share. | 0 |
| 05/05/2022 |
Jacqueline K. Barton Director |
2,444 | Award at $0 per share. | 0 |
| 05/05/2022 |
Harish M. Manwani Director |
2,444 | Award at $0 per share. | 0 |
| 05/05/2022 |
Javier J. Rodriguez Director |
2,444 | Award at $0 per share. | 0 |
| 05/05/2022 |
Anthony Welters Director |
2,444 | Award at $0 per share. | 0 |
| 05/05/2022 |
Jeffrey A. Bluestone Director |
2,444 | Award at $0 per share. | 0 |
| 05/05/2022 |
Harish M. Manwani Director |
477 | Derivative/Non-derivative trans. at $61.35 per share. | 29,263 |
| 05/03/2022 |
Kevin E. Lofton Director |
2,223 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 05/03/2022 |
Jacqueline K. Barton Director |
2,223 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 05/03/2022 |
Harish M. Manwani Director |
2,223 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 05/03/2022 |
Javier J. Rodriguez Director |
2,223 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 05/03/2022 |
Anthony Welters Director |
2,223 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 05/03/2022 |
Jeffrey A. Bluestone Director |
2,223 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 05/03/2022 |
Sandra J. Horning Director |
1,112 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 05/03/2022 |
Harish M. Manwani Director |
349 | Derivative/Non-derivative trans. at $60.33 per share. | 21,055 |
| 04/28/2022 |
Kevin E. Lofton Director |
16,322 | Derivative/Non-derivative trans. at $25.62 per share. | 418,169 |
| 03/11/2022 |
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel |
3,634 | Disposition at $58.24 per share. | 211,644 |
| 03/10/2022 |
Daniel P. O'Day Chairman & CEO; Director |
11,052 | Derivative/Non-derivative trans. at $57.92 per share. | 640,131 |
| 03/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
3,602 | Derivative/Non-derivative trans. at $57.92 per share. | 208,627 |
| 03/10/2022 |
Merdad V. Parsey Chief Medical Officer |
3,505 | Derivative/Non-derivative trans. at $57.92 per share. | 203,009 |
| 03/10/2022 |
Johanna Mercier Chief Commercial Officer |
3,221 | Derivative/Non-derivative trans. at $57.92 per share. | 186,560 |
| 03/10/2022 |
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel |
2,089 | Derivative/Non-derivative trans. at $57.92 per share. | 120,994 |
| 03/10/2022 |
Diane E. Wilfong SVP, Controller & CAO |
935 | Derivative/Non-derivative trans. at $57.92 per share. | 54,155 |
| 03/10/2022 |
Daniel P. O'Day Chairman & CEO; Director |
13,203 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Daniel P. O'Day Chairman & CEO; Director |
10,800 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
4,108 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
3,025 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
768 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Merdad V. Parsey Chief Medical Officer |
4,157 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Merdad V. Parsey Chief Medical Officer |
3,455 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Johanna Mercier Chief Commercial Officer |
3,962 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Johanna Mercier Chief Commercial Officer |
3,025 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel |
3,130 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel |
2,593 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Diane E. Wilfong SVP, Controller & CAO |
1,272 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2022 |
Diane E. Wilfong SVP, Controller & CAO |
2,025 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/01/2022 |
Daniel P. O'Day Chairman & CEO; Director |
23,245 | Derivative/Non-derivative trans. at $60.26 per share. | 1,400,743 |
| 03/01/2022 |
Daniel P. O'Day Chairman & CEO; Director |
42,922 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/01/2022 |
Daniel P. O'Day Chairman & CEO; Director |
11,362 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 02/15/2022 |
Andrew D. Dickinson Chief Financial Officer |
348 | Award at $52.13 per share. | 18,141 |
| 02/15/2022 |
Merdad V. Parsey Chief Medical Officer |
348 | Award at $52.13 per share. | 18,141 |
| 02/15/2022 |
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel |
348 | Award at $52.13 per share. | 18,141 |
| 02/09/2022 |
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel |
1,691 | Disposition at $63.89 per share. | 108,037 |
| 02/06/2022 |
Andrew D. Dickinson Chief Financial Officer |
767 | Derivative/Non-derivative trans. at $63.9 per share. | 49,011 |
| 02/06/2022 |
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel |
1,036 | Derivative/Non-derivative trans. at $63.9 per share. | 66,200 |
| 02/06/2022 |
Diane E. Wilfong SVP, Controller & CAO |
520 | Derivative/Non-derivative trans. at $63.9 per share. | 33,228 |
| 02/06/2022 |
Andrew D. Dickinson Chief Financial Officer |
1,817 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 02/06/2022 |
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel |
2,727 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 02/06/2022 |
Diane E. Wilfong SVP, Controller & CAO |
1,864 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 02/01/2022 |
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel |
14,061 | Disposition at $68.54 per share. | 963,740 |
